Poland· PL-100466647
Asmag B6 Forte
A magnesium citrate product containing magnesii citras + pyridoxini hydrochloridum, registered in Poland by Przedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Magnesium citrate is registered in 8 of 19 countries.
Countries holding a registration under ATC A12CC04 (magnesium citrate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Magnesium citrate · ATC A12CC04
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of magnesium citrate costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Magnesium citrate · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.99
The record
At a glance
URPL (Poland)- Active substance
- Magnesii citras + Pyridoxini hydrochloridum
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A12CC04
- ATC class
- Magnesium citrate
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05907573300481
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
305 interactions on record for magnesium citrate.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium citrate · interactions on record
305 records
- 4 severe
- 287 moderate
- 1 minor
Most severe, free to view
- DolutegravirJ05AJ03severe
- DolutegravirJ05AX12severe
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magnesium citrate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMAGNE B6Opella Healthcare Czech s.r.o., Praha
- FranceMAGNE B6 48 mg/5 mg, comprimé enrobéOPELLA HEALTHCARE FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Магне B6
- Czechia · Magne B6
- Estonia · Magne B6
- France · Magne B6, Magnesium/Vitamine B6 Biogaran Conseil
- Greece · Evrima-B6
- Hungary · Magne B6, Magne B6 Forte
- Lithuania · Magne B6
- Latvia · Magne B6, Magne B6 Premium
- Malta · Magnevie B6
- Romania · Magne B6, Magne B6 Forte
- Slovakia · Magne B6
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa3f29ce-9cb0-428d-9772-c2ce7b6c32da GET /v1/drugs/aa3f29ce-9cb0-428d-9772-c2ce7b6c32da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg Mg2+ + 10 mg",
"packaging": "05907573300481 ¦ OTC ¦ 161443\n50 tabl.",
"substance": "Magnesii citras 100 mg + Pyridoxini hydrochloridum 10 mg",
"common_name": "Magnesii citras + Pyridoxini hydrochloridum",
"pl_product_id": "100466647",
"pozwolenie_nr": "28972",
"auth_procedure": "NAR",
"authorisation_validity": "2030-08-13"
}See everything about magnesium citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.